The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.

Sherif M Badawy Antonios KattamisHatoon EzzatBenoît DeschampsEric SicardCaroline FradetteFeng ZhaoFernando TrictaYu Chung TsangSujit ShethAntonio Piga

Published in: British journal of haematology (2021)

Keyphrases

open label
study protocol
clinical trial
phase ii
phase iii
phase ii study
double blind
randomized controlled trial
physical activity
cross sectional
iron deficiency
placebo controlled
squamous cell carcinoma
radiation therapy